Acquisitions and Strategic Investments - Price Allocation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Feb. 20, 2023
Business Acquisition [Line Items]
Payment for acquisition, net of cash acquired (2)	$ 1,811	$ 1,542	$ 2,258
Fair value of contingent consideration	404	149	486
Cash	411	256
Goodwill	14,387	$ 12,920	$ 11,988
Acotec
Business Acquisition [Line Items]
Payment for acquisition, net of cash acquired (2)	381
Fair value of contingent consideration	0
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net	381
Cash				$ 140
Goodwill	337
Amortizable intangible assets	334
Other assets acquired	93
Liabilities assumed	(48)
Net deferred tax liabilities	(76)
Fair value of noncontrolling interest	(259)
Apollo
Business Acquisition [Line Items]
Payment for acquisition, net of cash acquired (2)	636
Fair value of contingent consideration	0
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net	636
Goodwill	378
Amortizable intangible assets	248
Other assets acquired	50
Liabilities assumed	(33)
Net deferred tax liabilities	(5)
Fair value of noncontrolling interest	0
Relievant Medsystems
Business Acquisition [Line Items]
Payment for acquisition, net of cash acquired (2)	794
Fair value of contingent consideration	273
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net	1,067
Goodwill	731
Amortizable intangible assets	325
Other assets acquired	24
Liabilities assumed	(15)
Net deferred tax liabilities	1
Fair value of noncontrolling interest	0
Baylis Medical
Business Acquisition [Line Items]
Payment for acquisition, net of cash acquired (2)	1,463
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net	1,463
Goodwill	988
Amortizable intangible assets	657
Other assets acquired	112
Liabilities assumed	(287)
Net deferred tax liabilities	$ (7)